ArticleBreast cancer (Tokyo, Japan)2025

A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer.

Yuko Kawai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.